Statistics in Medicine

Article	Citations
	361
Issue Information	201
Issue Information	126
Tracking the transmission dynamics of COVID‐19 with a time‐varying coefficient state‐space model	77
Modeling the multi‐state natural history of rare diseases with heterogeneous individual patient data: A simulation study	73
	53
Issue Information	53
Bayesian mixture modelling with ranked set samples	48
Semiparametric multivariate joint model for skewed‐longitudinal and survival data: A Bayesian approach	47
Balancing versus modelling in weighted analysis of non‐randomised studies with survival outcomes: A simulation study	44
Synthesizing studies for comparing different treatment sequences in clinical trials	44
Estimands for factorial trials	42
Transportability of model‐based estimands in evidence synthesis	40
	37
Improving main analysis by borrowing information from auxiliary data	36
Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies	36
Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule	36
Data fusion for predicting long‐term program impacts	33
Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances	32
BEATS: Bayesian hybrid design with flexible sample size adaptation for time‐to‐event endpoints	32
Leveraging External Aggregated Information for the Marginal Accelerated Failure Time Model	32
Incorporating survival data into case‐control studies with incident and prevalent cases	31
Robustness of κ‐type coefficients for clinical agreement	30
Optimal confidence intervals for the relative risk and odds ratio	30
Classification of disease recurrence using transition likelihoods with expectation‐maximization algorithm	30

	28
Network and covariate adjusted response‐adaptive design for binary response	27
	26
Handling parametric assumptions in principal causal effect estimation using Gaussian mixtures	26
Bayesian additive regression trees for multivariate skewed responses	26
Real time monitoring and prediction of time to endpoint maturation in clinical trials	26
The polytomous discrimination index for prediction involving multistate processes under intermittent observation	25
Confidence interval estimation for treatment effects in cluster randomization trials based on ranks	25
Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior	24
Bayesian model‐averaged meta‐analysis in medicine	24
A simulation study of disaggregation regression for spatial disease mapping	23
Discussion on “Is group testing ready for prime‐time in disease identification”	22
Evaluating joint confidence region of hypervolume under ROC manifold and generalized Youden index	22
Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs	21
Generalized additive models to analyze nonlinear trends in biomedical longitudinal data using R: Beyond repeated measures ANOVA and linear mixed models	20
An inverse probability weighted regression method that accounts for right‐censoring for causal inference with multiple treatments and a binary outcome	20
On the parameter estimation of Box‐Cox transformation cure model	20
Issue Information	20
Regression Trees With Fused Leaves	19
A shared‐parameter location‐scale mixed model to link the responsivity in self‐initiated event reports and the event‐contingent Ecological Momentary Assessments	19
A Hierarchical Bayesian Model for Estimating Age‐Specific COVID‐19 Infection Fatality Rates in Developing Countries	18
Estimating contact network properties by integrating multiple data sources associated with infectious diseases	18
Modeling intra‐individual inter‐trial EEG response variability in autism	17
Bayesian semiparametric joint modeling of longitudinal explanatory variables of mixed types and a binary outcome	16
Optimal adaptive allocation using deep reinforcement learning in a dose‐response study	16
Distribution–free hyperrectangular tolerance regions for setting multivariate reference regions in laboratory medicine	16
Multilevel joint model of longitudinal continuous and binary outcomes for hierarchically structured data	16
Modeling variation in mixture effects over space with a Bayesian spatially varying mixture model	16
A systematic review and evaluation of statistical methods for group variable selection	16
Multiple multi‐sample testing under arbitrary covariance dependency	16
	16
Standardization and other approaches to meta‐analyze differences in means	15
Instrumental variable model average with applications in Mendelian randomization	15
Variable selection for censored data using Modified Correlation Adjusted coRrelation (MCAR) scores	15
Finding the best subgroup with differential treatment effect with multiple outcomes	15
A combined multilevel factor analysis and covariance regression model with mixed effects in the mean and variance structure	15
A Bayesian method to detect drug‐drug interaction using external information for spontaneous reporting system	15
A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight	15
Relative sparsity for medical decision problems	15
Model‐assisted analyses of longitudinal, ordinal outcomes with absorbing states	14
Sensitivity analysis of G‐estimators to invalid instrumental variables	14
Nonparametric empirical Bayes biomarker imputation and estimation	14
Adjusted closed‐form confidence interval formulas for network meta‐analysis with a small number of studies	13
IDNetwork: A deep illness‐death network based on multi‐state event history process for disease prognostication	13
Multilevel Longitudinal Functional Principal Component Model	13
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low‐income adults	13
Asymptotic Confidence Interval, Sample Size Formulas and Comparison Test for the Agreement Intra‐Class Correlation Coefficient in Inter‐Rater Reliability Studies	13
Information‐incorporated sparse hierarchical cancer heterogeneity analysis	12
Kernel Cox partially linear regression: Building predictive models for cancer patients' survival	12
Estimating mixture effects and cumulative spatial risk over time simultaneously using a Bayesian index low‐rank kriging multiple membership model	12

Non‐Parametric Estimation for Semi‐Competing Risks Data With Event Misascertainment	12
A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart	12
A multivariate statistical approach to predict COVID‐19 count data with epidemiological interpretation and uncertainty quantification	12
Distribution‐free model selection for longitudinal zero‐inflated count data with missing responses and covariates	12
Quantile partially linear additive model for data with dropouts and an application to modeling cognitive decline	12
Covariate adjustment in randomized clinical trials with missing covariate and outcome data	12
Weighted McNemar's test for the comparison of two screening tests in the presence of verification bias	12
	12
Bayesian adaptive design for clinical trials in Duchenne muscular dystrophy	11
A Brief Introduction on Latent Variable Based Ordinal Regression Models With an Application to Survey Data	11
Obituary: Anthony Leonard Johnson (1943‐2022)	11
Issue Information	11
Genetic Prediction Modeling in Large Cohort Studies via Boosting Targeted Loss Functions	11
Flexible propensity score estimation strategies for clustered data in observational studies	11
Local false discovery rate estimation with competition‐based procedures for variable selection	11
Analysis of composite endpoints with component‐wise censoring in the presence of differential visit schedules	11
Issue Information	11
	11
Optimal weighted Bonferroni tests and their graphical extensions	11
	11
Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations	11
	11
Penalized smoothing splines resolve the curvature identifiability problem in age‐period‐cohort models with unequal intervals	10
Flexible template matching for observational study design	10
Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies	10
Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation	10
Handling missing within‐study correlations in the evaluation of surrogate endpoints	10
Issue Information	10
Robust inference for causal mediation analysis of recurrent event data	10
Joint regression modelling of intensity and timing of accelerometer counts	10
Modeling conditional reference regions: Application to glycemic markers	10
Frequentist Grouped Weighted Quantile Sum Regression for Correlated Chemical Mixtures	10
Issue Information	10
Structured time‐dependent inverse regression (STIR)	10
Correction to “Using principal stratification in analysis of clinical trials”	10
Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity	10
Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome	10
An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation	10
Using fractional polynomials and restricted cubic splines to model non‐proportional hazards or time‐varying covariate effects in the Cox regression model	10
Comment on Ellenberg and Morris: The role of statisticians in vaccine surveillance	10
	10
Complex survival trial design by the product integration method	10
Leveraging real‐world evidence for determining performance goals for medical device studies	9
Association analysis of self‐reported outcomes with a validated subset	9
Combining information to estimate adherence in studies of pre‐exposure prophylaxis for HIV prevention: Application to HPTN 067	9
Group sequential designs for clinical trials when the maximum sample size is uncertain	9
Bayesian sensitivity analyses for longitudinal data with dropouts that are potentially missing not at random: A high dimensional pattern‐mixture model	9
Q‐Learning in Dynamic Treatment Regimes With Misclassified Binary Outcome	9
New methods for multiple testing in permutation inference for the general linear model	9
Propensity score analysis with local balance	9
A non‐parametric Bayesian approach for adjusting partial compliance in sequential decision making	9
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial	9
BHAFT: Bayesian heredity‐constrained accelerated failure time models for detecting gene‐environment interactions in survival analysis	9
A tractable Bayesian joint model for longitudinal and survival data	8
Confidence intervals for odds ratio from multistage randomized phase II trials	8
Split and combine simulation extrapolation algorithm to correct geocoding coarsening of built environment exposures	8
Issue Information	8
Profile‐likelihood Bayesian model averaging for two‐sample summary data Mendelian randomization in the presence of horizontal pleiotropy	8
Multi‐threshold proportional hazards model and subgroup identification	8
A sequential, multiple assignment, randomized trial design with a tailoring function	8
The impact of correlated exposures and missing data on multiple informant models used to identify critical exposure windows	8
Issue Information	8
Sample size adaptations and evaluation of pediatric study interpretability	8
Statistical inference for time‐to‐event data in non‐randomized cohorts with selective attrition	8
	8
A nonparametric simultaneous confidence band for biomarker effect on the restricted mean survival time	8
Accounting for publication bias using a bivariate trim and fill meta‐analysis procedure	8
	8
MERIT: Controlling Monte‐Carlo error rate in large‐scale Monte‐Carlo hypothesis testing	8
Peter Armitage speaking on the occasion of the 50th Anniversary of the M.Sc. in Medical Statistics, LSHTM (for the Symposium on April 11‐12, 2019)	8
Minimization in randomized clinical trials	8
Scaled average bioequivalence methods for highly variable drugs: Leveling‐off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control)	8
Causal inference methods for vaccine sieve analysis with effect modification	8
Identification and robust estimation of swapped direct and indirect effects: Mediation analysis with unmeasured mediator‐outcome confounding and intermediate confounding	8
Issue Information	8
	7
The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints	7
A penalization approach to random‐effects meta‐analysis	7
Issue Information	7
Testing for the Functional Form of a Continuous Covariate in the Shared‐Parameter Joint Model	7

Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies	7
A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards	7
A Bayesian Multivariate Model With Temporal Dependence on Random Partition of Areal Data for Mosquito‐Borne Diseases	7
A Varying‐Coefficient Additive Hazard Model for Recurrent Events Data	7
Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints	7
Issue Information	7
	7
Weighted generalized estimating equations and unified estimation for longitudinal data with nonmonotone missing data patterns	7
Mixed‐type multivariate response regression with covariance estimation	7
Federated causal inference in heterogeneous observational data	7
Robust structured heterogeneity analysis approach for high‐dimensional data	7
Ensemble of Sequential Learning Models With Distributed Data Centers and Its Applications	7
Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data	7
On GEE for Mean‐Variance‐Correlation Models: Variance Estimation and Model Selection	7
Blinded sample size re‐estimation for comparing over‐dispersed count data incorporating follow‐up lengths	7
	7
A classification for complex imbalanced data in disease screening and early diagnosis	7
Saddlepoint approximations to score test statistics in logistic regression for analyzing genome‐wide association studies	7
A function‐based approach to model the measurement error in wearable devices	7
Sample size determination for prediction models via learning‐type curves	7
A distribution‐free procedure for testing versatile alternative in medical multisample comparison studies	6
Using a mixed‐effect model with a parameter‐space of heterogenous dimension to evaluate whether accountable care organizations are associated with greater uniformity across constituent practices	6
Fitting additive risk models using auxiliary information	6
Robust analysis of cancer heterogeneity for high‐dimensional data	6
Low‐rank latent matrix‐factor prediction modeling for generalized high‐dimensional matrix‐variate regression	6
A comparison of different methods to adjust survival curves for confounders	6
A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method	6
	6
Fast estimation of mixed‐effects location‐scale regression models	6
Synthesizing external aggregated information in the penalized Cox regression under population heterogeneity	6
Assessing heterogeneity in surrogacy using censored data	6
Measurement errors in control risk regression: A comparison of correction techniques	6
Fitting a stochastic model of intensive care occupancy to noisy hospitalization time series during the COVID‐19 pandemic	6
Comparing the sensitivities of two screening tests in nonblinded randomized paired screen‐positive trials with differential screening uptake	6
Using population crossover trials to improve the decision process regarding treatment individualization in N‐of‐1 trials	6
Exploiting relationship directionality to enhance statistical modeling of peer‐influence across social networks	6
Fusing trial data for treatment comparisons: Single vs multi‐span bridging	6
A Bayesian semi‐parametric scalar‐on‐function regression with measurement error using instrumental variables	6
Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data	6
Allocation in platform trials to maintain comparability across time and eligibility	6
Penalized maximum likelihood inference under the mixture cure model in sparse data	6
Set‐regression with applications to subgroup analysis	6
Optimal allocation in stratified cluster‐based outcome‐dependent sampling designs	6
Trial emulation and survival analysis for disease incidence registers: A case study on the causal effect of pre‐emptive kidney transplantation	6
Subgroup analysis using Bernoulli‐gated hierarchical mixtures of experts models	6
Bayesian predictive model averaging approach to joint longitudinal‐survival modeling: Application to an immuno‐oncology clinical trial	6
Depthgram: Visualizing outliers in high‐dimensional functional data with application to fMRI data exploration	6
Multiple imputation approaches for handling incomplete three‐level data with time‐varying cluster‐memberships	6
Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo	6
Multiblock partial least squares and rank aggregation: Applications to detection of bacteriophages associated with antimicrobial resistance in the presence of potential confounding factors	6
Properties of the full random‐effect modeling approach with missing covariate data	6
A conditional autoregressive model for genetic association analysis accounting for genetic heterogeneity	6
Issue Information	6
A proper statistical inference framework to compare clinical trial and real‐world progression‐free survival data	6
Randomization‐based inference for a marginal treatment effect in stepped wedge cluster randomized trials	6
Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs	6
Approximate likelihood‐based estimation method of multiple‐type pathogen interactions: An application to longitudinal pneumococcal carriage data	6
Multivariate functional mixed model with MRI data: An application to Alzheimer's disease	6
Parameter estimation and forecasting with quantified uncertainty for ordinary differential equation models using QuantDiffForecast: A MATLAB toolbox and tutorial	6
Robust group variable screening based on maximum Lq‐likelihood estimation	5
Issue Information	5
Issue Information	5
Sensitivity analysis with iterative outlier detection for systematic reviews and meta‐analyses	5
Deep reinforcement learning for personalized treatment recommendation	5
Robust inference methods for meta‐analysis involving influential outlying studies	5
	5
Sensitivity Analysis for Effects of Multiple Exposures in the Presence of Unmeasured Confounding: Non‐Gaussian and Time‐to‐Event Outcomes	5
	5
Integrative deep learning with prior assisted feature selection	5
Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis	5
Nonparametric estimation of marked survival data in the presence of dependent censoring	5
Issue Information	5
New late‐emphasis and combination tests based on infimum and supremum logrank statistics with application in oncology trials	5
Testing a global null hypothesis using ensemble machine learning methods	5
Progression models for repeated measures: Estimating novel treatment effects in progressive diseases	5
Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling	5
A Novel Bayesian Spatio‐Temporal Surveillance Metric to Predict Emerging Infectious Disease Areas of High Disease Risk	5
A two‐stage prediction model for heterogeneous effects of treatments	5
Point estimation for adaptive trial designs II: Practical considerations and guidance	5
	5
Distributional imputation for the analysis of censored recurrent events	5
Approximate maximum likelihood estimation in cure models using aggregated data, with application to HPV vaccine completion	5
Joint analysis of longitudinal measurements and spatially clustered competing risksHIV/AIDSdata	5
Event‐specific win ratios for inference with terminal and non‐terminal events	5
SIM 40th Anniversary	5
Spatial modeling of epidermal nerve fiber patterns	5
Using generalized linear models to implement g‐estimation for survival data with time‐varying confounding	5
Targeted maximum likelihood estimation of causal effects with interference: A simulation study	5
A Bayesian non‐stationary heteroskedastic time series model for multivariate critical care data	5
Planning stepped wedge cluster randomized trials to detect treatment effect heterogeneity	5
Reinforced Borrowing Framework: Leveraging Auxiliary Data for Individualized Inference	5
Survival mediation analysis with the death‐truncated mediator: The completeness of the survival mediation parameter	5
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials	5
Joint modeling approaches for censored predictors due to detection limits with applications to metabolites data	5
Individualized empirical null estimation for exact tests of healthcare quality	5